Skip to main content
Content Starts Here GSA Federal Advisory Committee Act (FACA) Database Skip to main content

Committee Detail

Hide Section - GENERAL INFORMATION

GENERAL INFORMATION

Committee NameNational Mammography Quality Assurance Advisory CommitteeAgency NameDepartment of Health and Human Services
Fiscal Year2019Committee Number1671
Original Establishment Date7/6/1993Committee StatusChartered
Actual Termination Date Committee URLhttp://www.fda.gov/AdvisoryCommittees/Committee...
New Committee This FYNoPresidential Appointments*No
Terminated This FYNoMax Number of Members*15
Current Charter Date7/7/2017Designated Fed Officer Position Title*Senior Regulatory Review Officer, Center for Devices and Radiological Health/FDA
Date Of Renewal Charter7/7/2019Designated Federal Officer PrefixCDR
Projected Termination Date Designated Federal Officer First Name*Sara
Exempt From Renewal*NoDesignated Federal Officer Middle Name
Specific Termination AuthorityDesignated Federal Officer Last Name*Anderson
Establishment Authority*Statutory (Congress Created)Designated Federal Officer Suffix
Specific Establishment Authority*42 U.S.C. 263(b)Designated Federal Officer Phone*(301) 796-7047
Effective Date Of Authority*7/6/1991Designated Federal Officer Fax*(301) 847-8121
Committee Type*ContinuingDesignated Federal Officer Email*sara.anderson@fda.hhs.gov
Presidential*No
Committee Function*Scientific Technical Program Advisory Board
Hide Section - RECOMMENDATION/JUSTIFICATIONS

RECOMMENDATION/JUSTIFICATIONS

Agency Recommendation*Continue
Legislation to Terminate RequiredNot Applicable
Legislation StatusNot Applicable
How does cmte accomplish its purpose?*The National Mammography Quality Assurance Advisory Committee (NMQAAC) provides advice to the Agency on the following tasks: (1) developing appropriate quality standards and regulations for mammography facilities, (2) developing appropriate standards and regulation for bodies accrediting mammography facilities, (3) developing regulations on sanctions, (4) developing procedures to monitor compliance with standards, (5) establishing a mechanism to investigate consumer complaints, (6) reporting new developments concerning breast imaging that should be considered in the oversight of mammography facilities, (7) determining whether there is a shortage of mammography facilities in rural and health professional shortage areas, (8) determining whether there will be a sufficient number of medical physicists after 1999, and (9) determining the costs and benefits of compliance with these requirements.
How is membership balanced?*The Mammography Quality Standards Act of 1992 (MQSA) specifies that advisory committee members be selected from physicians, practitioners and other health professionals whose clinical practice, research specialization, or professional expertise includes a significant focus on mammography. The Act also directs the appointment of four individuals from among national breast cancer consumer health organizations with expertise in mammography and at least two practicing physicians who provide mammography services. The current committee is composed of M.D.'s and Ph.D's who have expertise in the fields of medical physics, teleradiology, medical physicist, digital mammography, and diagnostic radiology. Consumer interests are represented by mammographers, radiologic technologists and health education specialists.
How frequent & relevant are cmte mtgs?*This committee is mandated by the Mammography Quality Standards Act of 1992 (MQSA) to provide input in the promulgation of reasonable policies to execute the Act. Meetings are to be held annually.
Why advice can't be obtained elsewhere?*Committee members have backgrounds in academia, research, and/or clinical practice. Their advice and input lends credibility to regulation decisions made and assists those decisions to stand up to intense public scrutiny. The alternate means of accessing this advice would involve the recruitment of large numbers of scientists on a full-time basis at maximum rates of compensation.
Why close or partially close meetings?N/A
Recommendation RemarksAlthough this committee did not meet in FY 2018, considerable time was devoted to reappointing current members, maintaining associated records for these activities, and streamlining paper processes within FDA. In addition, time was spent in the routine care and maintenance of the committee: the development of a financial report for this website; updating the roster and number of vacancies on our website; completing the annual ethics report; reviewing financial disclosures of current members and providing ethics training. Since the Committee did not meet, no reporting was required.
Hide Section - PERFORMANCE MEASURES

PERFORMANCE MEASURES

Outcome Improvement To Health Or Safety*YesAction Reorganize Priorities*Yes
Outcome Trust In GovernmentYesAction Reallocate ResourcesNo
Outcome Major Policy ChangesYesAction Issued New RegulationsYes
Outcome Advance In Scientific ResearchYesAction Proposed LegislationNo
Outcome Effective Grant MakingNoAction Approved Grants Or Other PaymentsNo
Outcome Improved Service DeliveryNoAction OtherYes
Outcome Increased Customer SatisfactionYesAction CommentIssued new or modified guidance.
Outcome Implement Laws/Reg RequirementsYesGrants Review*No
Outcome OtherNoNumber Of Grants Reviewed0
Outcome CommentNANumber Of Grants Recommended0
Cost Savings*Unable to DetermineDollar Value Of Grants Recommended$0.00
Cost Savings CommentThe utilization of the National Mammography Quality Assurance Advisory Committee enables the Agency to obtain required and frequently scarce professional services from medical and scientific experts not otherwise available to the Agency; and to obtain the services of these experts only on an as needed basis rather than on a full time basis . The service of the Committee resulted in advice for the improvement of the public health, for which it is difficult to assign a financial value.Grants Review CommentNA
Number Of Recommendations*87Access Contact Designated Fed. Officer*Yes
Number Of Recommendations CommentThe committee made 87 recommendations from FY03 through FY18---See question 20a of the annual report or specific accomplishmentsAccess Agency WebsiteYes
% of Recs Fully Implemented*85.00%Access Committee WebsiteYes
% of Recs Fully Implemented CommentThe function of an advisory committee is purely advisory in nature. Although the FDA often accepts the recommendations from its committees, the advice is purely advisory in nature, therefore, the Agency has the option of not implementing the advice.Access GSA FACA WebsiteYes
% of Recs Partially Implemented*15.00%Access PublicationsYes
% of Recs Partially Implemented CommentThe function of an advisory committee is purely advisory in nature. Although the FDA most often accepts the recommendations from its committees, the advice is purely advisory in nature, and therefore, the Agency has the option of not implementing the advice.Access OtherNo
Agency Feedback*YesAccess CommentN/A
Agency Feedback CommentMost of the committee’s recommendations deal with guidance. When the guidance has been finalized, the committee is sent copies of the guidance.Narrative Description*FDA's strategic priorities in responding to the public health challenges of the 21st century are to advance regulatory science and innovation; strengthen the safety and integrity of the global supply chain; strengthen compliance and enforcement activities to support public health; expand efforts to meet the needs of special populations; advance medical countermeasures and emergency preparedness; advance food safety and nutrition; promote public health by advancing the safety and effectiveness of medical products; establish an effective tobacco regulation, prevention, and control program; and manage for organizational excellence and accountability. The National Mammography Quality Assurance Advisory Committee (NMQAAC) supports FDA's strategic priorities by advising the Food and Drug Administration on the following items, thereby helping FDA meet Objective 3 of Empowering Consumers by improving and increasing FDA-initiated health benefit/risk information:(A)developing appropriate quality standards and regulations for mammography facilities; (B)developing appropriate standards and regulations for bodies accrediting mammography facilities under this program; (C)developing regulations with respect to sanctions;(D)developing procedures for monitoring compliance with standards;(E)establishing a mechanism to investigate consumer complaints;(F)reporting new developments concerning breast imaging which should be considered in the oversight of mammography facilities;(G)determining whether there exists a shortage of mammography facilities in rural and health professional shortage areas and determining the effects of personnel on access to the services of such facilities in such areas; (H)determining whether there will exist a sufficient number of medical physicists after October 1, 1999; and (I)determining the costs and benefits of compliance with these requirements.
Hide Section - COSTS

COSTS

Payments to Non-Federal Members* Est Payments to Non-Fed Members Next FY* 
Payments to Federal Members* Est. Payments to Fed Members Next FY* 
Payments to Federal Staff* Estimated Payments to Federal Staff* 
Payments to Consultants* Est. Payments to Consultants Next FY* 
Travel Reimb. For Non-Federal Members* Est Travel Reimb Non-Fed Members nextFY* 
Travel Reimb. For Federal Members* Est Travel Reimb For Fed Members* 
Travel Reimb. For Federal Staff* Est. Travel Reimb to Fed Staff Next FY* 
Travel Reimb. For Consultants* Est Travel Reimb to Consultants Next FY* 
Other Costs Est. Other Costs Next FY* 
Total Costs$0.00Est. Total Next FY*$0.00
Federal Staff Support (FTE)* Est. Fed Staff Support Next FY* 
Hide Section - Custom Links

Custom Links

     Committee Level Reports               
Hide Section - MEMBERS,MEETINGS AND ADVISORY REPORTS

MEMBERS,MEETINGS AND ADVISORY REPORTS

To View all the members, meetings and advisory reports for this committee please click here
Hide Section - CHARTERS AND RELATED DOCS

CHARTERS AND RELATED DOCS

No Documents Found
Hide Section - DATA FROM PREVIOUS YEARS

DATA FROM PREVIOUS YEARS

Committee

Data from Previous Years

 
ActionCommittee System IDCommittee NameFiscal Year
 COM-002005National Mammography Quality Assurance Advisory Committee2017
 COM-002253National Mammography Quality Assurance Advisory Committee2016
 COM-003760National Mammography Quality Assurance Advisory Committee2015
 COM-004364National Mammography Quality Assurance Advisory Committee2014
 COM-006232National Mammography Quality Assurance Advisory Committee2013
 COM-006911National Mammography Quality Assurance Advisory Committee2012
 COM-008338National Mammography Quality Assurance Advisory Committee2011
 COM-009009National Mammography Quality Assurance Advisory Committee2010
 COM-010063National Mammography Quality Assurance Advisory Committee2009
 COM-010951National Mammography Quality Assurance Advisory Committee2008
 COM-012201National Mammography Quality Assurance Advisory Committee2007
 COM-012546National Mammography Quality Assurance Advisory Committee2006
 COM-013925National Mammography Quality Assurance Advisory Committee2005
 COM-014683National Mammography Quality Assurance Advisory Committee2004
 COM-016008National Mammography Quality Assurance Advisory Committee2003
 COM-016723National Mammography Quality Assurance Advisory Committee2002
 COM-017616National Mammography Quality Assurance Advisory Committee2001
 COM-018411National Mammography Quality Assurance Advisory Committee2000
 COM-019573National Mammography Quality Assurance Advisory Committee1999
 COM-020567National Mammography Quality Assurance Advisory Committee1998
 COM-021603National Mammography Quality Assurance Advisory Committee1997
 COM-034844National Mammography Quality Assurance Advisory Committee2018